Trials / Sponsors / Tenax Therapeutics, Inc.
Tenax Therapeutics, Inc.
Industry · 9 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Enrolling By Invitation | Long-Term Open-Label Extension Study of Oral Levosimendan Pulmonary Hypertension Associated With HFpEF | Phase 3 | 2026-03-13 |
| Recruiting | LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2 Pulmonary Hypertension Associated With HFpEF | Phase 3 | 2026-03-03 |
| Recruiting | LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF Pulmonary Hypertension | Phase 3 | 2024-01-10 |
| Completed | Open-Label Rollover Study of Levosimendan in PH-HFpEF Patients Hypertension Pulmonary Secondary Heart Failure, Right Sided Heart Failure With Normal Ejection Fraction, Heart Failure With Normal Ejection Fraction | Phase 2 | 2018-11-14 |
| Completed | Hemodynamic Evaluation of Levosimendan in Patients With PH-HFpEF Hypertension Pulmonary Secondary, Heart Failure, Right Sided, Heart Failure With Normal Ejection Fraction | Phase 2 | 2018-11-14 |
| Completed | Levosimendan in Patients With Left Ventricular Systolic Dysfunction Undergoing Cardiac Surgery On Cardiopulmon Coronary Artery Bypass Grafting, Mitral Valve Surgery, Low Cardiac Output Syndrome | Phase 3 | 2014-07-01 |
| Terminated | Safety and Tolerability of Oxycyte in Patients With Traumatic Brain Injury (TBI) Traumatic Brain Injury | Phase 2 | 2009-10-01 |
| Terminated | Study of Oxycyte in Severe Closed Head Injury Traumatic Brain Injury | Phase 2 | 2005-09-01 |
| No Longer Available | Levosimendan Compassionate Use in Pediatric Patients With Advanced Decompensated Heart Failure Heart Decompensation | — | — |